[Market Study] Global Covid Testing Kit Market is expected to hit US$ 52.2 billion by 2028, registering a substantial CAGR of over 19.8%, market report by RationalStat
17 août 2023 10h00 HE
|
Rationalstat LLC
Wilmington, Delaware, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Market Scope and Report Overview Organizations that are driving market expansion have been making more developments. For instance, in...
60 Degrees Pharmaceuticals Registers ACLR8-LR, a Phase IIB Study of Tafenoquine for Treatment of COVID-19, on ClinicalTrials.gov
15 août 2023 07h31 HE
|
Sixty Degrees Pharmaceuticals
ACLR8-LR, a double-blind, randomized, placebo-controlled Phase IIB study to determine efficacy of the ARAKODA® regimen of tafenoquine in COVID-19 patients with mild-moderate symptoms and low risk of...
BrainHQ selected for NIH-funded Study for Long Covid Cognitive Issues
02 août 2023 08h00 HE
|
Posit Science
SAN FRANCISCO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- As announced by the US National Institutes of Health (NIH), BrainHQ is being incorporated into phase 2 clinical trials addressing persistent...
SSA’s New Guide: A Positive Step For Long COVID Sufferers, Allsup Ready To Assist With SSDI Claims
31 juil. 2023 16h49 HE
|
Allsup
Belleville, Illinois, July 31, 2023 (GLOBE NEWSWIRE) -- The Social Security Administration (SSA) has issued new guidance for long COVID sufferers. The guide offers a clearer picture as to how this...
Intesa Sanpaolo presents Industrial Districts Report. Gros-Pietro, excellent rebound from Covid
19 juil. 2023 05h19 HE
|
Intesa Sanpaolo
MILAN, Italy, July 19, 2023 (GLOBE NEWSWIRE) -- Focus on the rebound of businesses after the pandemic in Intesa Sanpaolo's "Economy and Finance of Industrial Districts 2022" Report, now in its 15th...
Danaher (DHR) Faces Shareholder Class Action Lawsuit: Johnson Fistel Encourages Investors with Losses Exceeding $100,000 to Seek Representation
18 juil. 2023 12h10 HE
|
Johnson Fistel, LLP
SAN DIEGO, July 18, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP, a shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of Danaher Corporation ("Danaher" or...
Sirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEB
28 juin 2023 09h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, June 28, 2023 (GLOBE NEWSWIRE) -- June 28, 2023 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) ("Sirona") is excited to announce the development of a...
InflaRx Appoints Dr. Camilla Chong as Chief Medical Officer
28 juin 2023 07h30 HE
|
InflaRx N.V.
Camilla Chong, M.D., joins the team with 25 years of experience in the global pharmaceutical industry in drug developmentDr. Chong to lead clinical development of InflaRx’s portfolio of C5a/C5aR...
InflaRx Announces Commercial Launch of Gohibic (vilobelimab) in the U.S. for the Treatment of Critically Ill COVID-19 Patients
21 juin 2023 07h00 HE
|
InflaRx N.V.
Gohibic is now commercially available for hospitals in the U.S.Gohibic can be used under an Emergency Use Authorization (EUA) granted by the FDA for treatment of certain critically ill COVID-19...
Hospitals Improperly Refuse to Allow Ivermectin for COVID and Yet Defend Right to Do So, according to Journal of American Physicians and Surgeons
19 juin 2023 14h07 HE
|
Association of American Physicians and Surgeons
TUCSON, Ariz., June 19, 2023 (GLOBE NEWSWIRE) -- A number of hospitals have been sued for refusing to allow patients dying of COVID to receive treatment with ivermectin. If the hospital lost, it...